Bacterial endocarditis: Difference between revisions
Jump to navigation
Jump to search
imported>Robert Badgett (New page: ==Prevention== According to clinical practice guidelines from the American Heart Association, the following patients are "Highest Risk of Adverse Outcome From Endocarditis for Which Proph...) |
imported>Robert Badgett No edit summary |
||
| Line 1: | Line 1: | ||
Endocarditis is defined at "Exudative and proliferative inflammatory alterations of the endocardium, characterized by the presence of vegetations on the surface of the endocardium or in the endocardium itself, and most commonly involving a heart valve, but sometimes affecting the inner lining of the cardiac chambers or the endocardium elsewhere. It may occur as a primary disorder or as a complication of or in association with another disease".<ref>{{cite web |url=http://www.nlm.nih.gov/cgi/mesh/2007/MB_cgi?mode=&term=Endocarditis |title=Endocarditis|author=National Library of Medicine |accessdate=2007-10-19 |format= |work=}}</ref> | |||
==Prevention== | ==Prevention== | ||
According to [[clinical practice guideline]]s from the [[American Heart Association]], the following patients are "Highest Risk of Adverse Outcome From Endocarditis for Which Prophylaxis With Dental Procedures Is Reasonable" if they are undergoing "dental procedures that involve manipulation of gingival tissue or the periapical region of teeth or perforation of the oral mucosa":<ref name="pmid17446442">{{cite journal |author=Wilson W, Taubert KA, Gewitz M, ''et al'' |title=Prevention of infective endocarditis: guidelines from the American Heart Association: a guideline from the American Heart Association Rheumatic Fever, Endocarditis, and Kawasaki Disease Committee, Council on Cardiovascular Disease in the Young, and the Council on Clinical Cardiology, Council on Cardiovascular Surgery and Anesthesia, and the Quality of Care and Outcomes Research Interdisciplinary Working Group |journal=Circulation |volume=116 |issue=15 |pages=1736–54 |year=2007 |pmid=17446442 |doi=10.1161/CIRCULATIONAHA.106.183095}}</ref> | |||
According to clinical practice | |||
* "Prosthetic cardiac valve or prosthetic material used for cardiac valve repair" | * "Prosthetic cardiac valve or prosthetic material used for cardiac valve repair" | ||
* "Previous IE [infective endocarditis]" | * "Previous IE [infective endocarditis]" | ||
Revision as of 09:51, 19 October 2007
Endocarditis is defined at "Exudative and proliferative inflammatory alterations of the endocardium, characterized by the presence of vegetations on the surface of the endocardium or in the endocardium itself, and most commonly involving a heart valve, but sometimes affecting the inner lining of the cardiac chambers or the endocardium elsewhere. It may occur as a primary disorder or as a complication of or in association with another disease".[1]
Prevention
According to clinical practice guidelines from the American Heart Association, the following patients are "Highest Risk of Adverse Outcome From Endocarditis for Which Prophylaxis With Dental Procedures Is Reasonable" if they are undergoing "dental procedures that involve manipulation of gingival tissue or the periapical region of teeth or perforation of the oral mucosa":[2]
- "Prosthetic cardiac valve or prosthetic material used for cardiac valve repair"
- "Previous IE [infective endocarditis]"
- "Congenital heart disease (CHD)*"
- "Unrepaired cyanotic CHD, including palliative shunts and conduits"
- "Completely repaired congenital heart defect with prosthetic material or device, whether placed by surgery or by catheter intervention, during the first 6 months after the procedure"
- "Repaired CHD with residual defects at the site or adjacent to the site of a prosthetic patch or prosthetic device (which inhibit endothelialization)"
- Cardiac transplantation recipients who develop cardiac valvulopathy
References
- ↑ National Library of Medicine. Endocarditis. Retrieved on 2007-10-19.
- ↑ Wilson W, Taubert KA, Gewitz M, et al (2007). "Prevention of infective endocarditis: guidelines from the American Heart Association: a guideline from the American Heart Association Rheumatic Fever, Endocarditis, and Kawasaki Disease Committee, Council on Cardiovascular Disease in the Young, and the Council on Clinical Cardiology, Council on Cardiovascular Surgery and Anesthesia, and the Quality of Care and Outcomes Research Interdisciplinary Working Group". Circulation 116 (15): 1736–54. DOI:10.1161/CIRCULATIONAHA.106.183095. PMID 17446442. Research Blogging.